 Irina Petrache
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 35 | 2024 | 275 | 9.430 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 25 | 2026 | 923 | 5.090 |
Why?
| | Ceramides | 24 | 2025 | 116 | 5.040 |
Why?
| | alpha 1-Antitrypsin | 15 | 2023 | 102 | 4.820 |
Why?
| | Lung | 55 | 2025 | 4109 | 4.190 |
Why?
| | Apoptosis | 39 | 2025 | 2430 | 3.890 |
Why?
| | Lung Injury | 12 | 2025 | 237 | 3.830 |
Why?
| | Smoking | 30 | 2020 | 1472 | 3.810 |
Why?
| | Endothelial Cells | 25 | 2025 | 870 | 3.780 |
Why?
| | Cigarette Smoking | 8 | 2022 | 99 | 3.230 |
Why?
| | Smoke | 12 | 2021 | 148 | 2.900 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 108 | 2.700 |
Why?
| | Emphysema | 10 | 2023 | 100 | 2.340 |
Why?
| | Sphingomyelin Phosphodiesterase | 7 | 2025 | 27 | 2.310 |
Why?
| | Sphingolipids | 8 | 2025 | 83 | 2.310 |
Why?
| | alpha 1-Antitrypsin Deficiency | 8 | 2019 | 59 | 2.080 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 383 | 2.020 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 368 | 2.000 |
Why?
| | Acute Lung Injury | 4 | 2025 | 303 | 1.790 |
Why?
| | Hypertension, Pulmonary | 10 | 2026 | 1980 | 1.690 |
Why?
| | Vaping | 3 | 2023 | 66 | 1.490 |
Why?
| | Animals | 89 | 2025 | 38109 | 1.330 |
Why?
| | Tobacco Products | 5 | 2021 | 84 | 1.320 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 965 | 1.300 |
Why?
| | Mice | 58 | 2025 | 18365 | 1.280 |
Why?
| | Microvessels | 4 | 2021 | 99 | 1.230 |
Why?
| | Signal Transduction | 19 | 2020 | 5233 | 1.150 |
Why?
| | Oxidative Stress | 13 | 2020 | 1339 | 1.140 |
Why?
| | Cells, Cultured | 23 | 2021 | 4155 | 1.130 |
Why?
| | Autophagy | 7 | 2021 | 286 | 1.110 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1217 | 1.110 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 120 | 1.060 |
Why?
| | Mice, Inbred C57BL | 28 | 2025 | 5997 | 1.050 |
Why?
| | MicroRNAs | 3 | 2026 | 701 | 1.030 |
Why?
| | Disease Models, Animal | 16 | 2022 | 4569 | 0.990 |
Why?
| | Pneumonia | 5 | 2021 | 631 | 0.960 |
Why?
| | Lipopolysaccharides | 5 | 2025 | 863 | 0.950 |
Why?
| | Caspase 3 | 7 | 2016 | 238 | 0.940 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 457 | 0.910 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1134 | 0.910 |
Why?
| | Membrane Proteins | 5 | 2022 | 1167 | 0.890 |
Why?
| | Inflammation | 9 | 2025 | 2880 | 0.870 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 233 | 0.860 |
Why?
| | Hypoxia | 6 | 2020 | 1199 | 0.860 |
Why?
| | Adipose Tissue | 5 | 2017 | 653 | 0.860 |
Why?
| | Rats | 22 | 2017 | 5614 | 0.840 |
Why?
| | Up-Regulation | 10 | 2020 | 852 | 0.840 |
Why?
| | Humans | 101 | 2026 | 144957 | 0.840 |
Why?
| | Endothelium | 4 | 2023 | 119 | 0.830 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 194 | 0.830 |
Why?
| | Endocytosis | 3 | 2016 | 168 | 0.820 |
Why?
| | Vascular System Injuries | 1 | 2023 | 77 | 0.730 |
Why?
| | Mice, Knockout | 12 | 2025 | 3125 | 0.700 |
Why?
| | Phagocytosis | 3 | 2021 | 299 | 0.690 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.690 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.690 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.680 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2540 | 0.650 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 17 | 0.630 |
Why?
| | Glucosylceramides | 1 | 2019 | 7 | 0.620 |
Why?
| | Translocation, Genetic | 1 | 2020 | 118 | 0.620 |
Why?
| | Immunoglobulins | 1 | 2020 | 160 | 0.610 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 208 | 0.610 |
Why?
| | Proteomics | 2 | 2026 | 1195 | 0.610 |
Why?
| | Glycoproteins | 1 | 2021 | 355 | 0.580 |
Why?
| | Estradiol | 3 | 2018 | 533 | 0.580 |
Why?
| | Epithelial Cells | 10 | 2022 | 1126 | 0.580 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 23 | 0.580 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 826 | 0.570 |
Why?
| | Macrophages | 4 | 2021 | 1511 | 0.570 |
Why?
| | Influenza, Human | 2 | 2022 | 617 | 0.560 |
Why?
| | Alpha-Globulins | 1 | 2018 | 19 | 0.560 |
Why?
| | Lysosomes | 2 | 2021 | 128 | 0.560 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 23 | 0.550 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 9 | 0.550 |
Why?
| | Sphingosine | 5 | 2015 | 45 | 0.550 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 444 | 0.550 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 341 | 0.540 |
Why?
| | Lung Diseases | 4 | 2025 | 787 | 0.540 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.540 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 636 | 0.530 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 6 | 0.530 |
Why?
| | Metformin | 1 | 2021 | 319 | 0.530 |
Why?
| | Thorax | 2 | 2022 | 50 | 0.520 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 464 | 0.510 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 172 | 0.490 |
Why?
| | Cell Death | 4 | 2019 | 383 | 0.490 |
Why?
| | Cell Movement | 4 | 2020 | 965 | 0.480 |
Why?
| | Male | 45 | 2026 | 72406 | 0.480 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 14 | 0.460 |
Why?
| | DNA Repair | 1 | 2018 | 256 | 0.460 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 75 | 0.450 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2365 | 0.450 |
Why?
| | Telemetry | 1 | 2015 | 41 | 0.450 |
Why?
| | Cosmic Radiation | 1 | 2014 | 5 | 0.440 |
Why?
| | Cytokines | 9 | 2019 | 2065 | 0.440 |
Why?
| | ADAM Proteins | 3 | 2022 | 63 | 0.440 |
Why?
| | DNA Damage | 1 | 2018 | 430 | 0.440 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 68 | 0.430 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2185 | 0.430 |
Why?
| | Female | 36 | 2026 | 78376 | 0.430 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.420 |
Why?
| | Oxidoreductases | 4 | 2011 | 96 | 0.420 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 269 | 0.420 |
Why?
| | Palmitic Acids | 1 | 2014 | 10 | 0.420 |
Why?
| | Alginates | 1 | 2014 | 49 | 0.420 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 13 | 0.420 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 81 | 0.410 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 79 | 0.410 |
Why?
| | Enzyme Activation | 8 | 2015 | 768 | 0.410 |
Why?
| | Cell Proliferation | 9 | 2020 | 2499 | 0.410 |
Why?
| | Spinal Injuries | 1 | 2014 | 58 | 0.400 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 137 | 0.400 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 191 | 0.390 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 7 | 0.380 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.370 |
Why?
| | Lysophospholipids | 5 | 2015 | 77 | 0.370 |
Why?
| | Interleukin-6 | 1 | 2016 | 780 | 0.370 |
Why?
| | Nicotine | 1 | 2015 | 332 | 0.370 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 221 | 0.360 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1158 | 0.350 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 356 | 0.350 |
Why?
| | Biomarkers | 9 | 2026 | 4275 | 0.350 |
Why?
| | Metabolomics | 5 | 2018 | 727 | 0.340 |
Why?
| | Estrogens | 1 | 2014 | 380 | 0.340 |
Why?
| | Photons | 1 | 2011 | 76 | 0.330 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 56 | 0.330 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 321 | 0.330 |
Why?
| | Stress, Physiological | 1 | 2014 | 453 | 0.320 |
Why?
| | Cell Differentiation | 2 | 2018 | 2050 | 0.320 |
Why?
| | Exercise Therapy | 1 | 2015 | 473 | 0.320 |
Why?
| | Virus Diseases | 2 | 2023 | 216 | 0.320 |
Why?
| | Adult Stem Cells | 1 | 2010 | 39 | 0.320 |
Why?
| | Hemodynamics | 1 | 2015 | 1121 | 0.310 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2032 | 0.310 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 55 | 0.310 |
Why?
| | Caspases | 3 | 2011 | 232 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.290 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 301 | 0.290 |
Why?
| | Phenotype | 7 | 2020 | 3164 | 0.290 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 39 | 0.280 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 339 | 0.280 |
Why?
| | Sphingomyelins | 3 | 2025 | 22 | 0.280 |
Why?
| | Vascular Remodeling | 4 | 2025 | 205 | 0.280 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 451 | 0.280 |
Why?
| | Mass Spectrometry | 4 | 2018 | 750 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 561 | 0.260 |
Why?
| | Fibrinolysin | 1 | 2007 | 19 | 0.260 |
Why?
| | Heart | 1 | 2011 | 636 | 0.260 |
Why?
| | Predictive Value of Tests | 3 | 2026 | 2118 | 0.250 |
Why?
| | Transcription Factors | 2 | 2012 | 1742 | 0.250 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 150 | 0.250 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1500 | 0.250 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 635 | 0.240 |
Why?
| | Electric Impedance | 3 | 2015 | 111 | 0.240 |
Why?
| | Thrombin | 1 | 2007 | 166 | 0.240 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 109 | 0.240 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2609 | 0.230 |
Why?
| | ADAM17 Protein | 2 | 2017 | 42 | 0.230 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 187 | 0.230 |
Why?
| | Middle Aged | 12 | 2026 | 35928 | 0.220 |
Why?
| | Leukocytes | 3 | 2022 | 295 | 0.220 |
Why?
| | Cell Adhesion | 2 | 2020 | 455 | 0.220 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 370 | 0.220 |
Why?
| | Forced Expiratory Volume | 1 | 2026 | 449 | 0.220 |
Why?
| | Caspase 6 | 2 | 2016 | 3 | 0.210 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 131 | 0.210 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 675 | 0.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 25 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2738 | 0.200 |
Why?
| | Capillary Permeability | 2 | 2015 | 134 | 0.200 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 17 | 0.200 |
Why?
| | Homeostasis | 3 | 2018 | 640 | 0.200 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 19 | 0.190 |
Why?
| | Monocytes | 4 | 2023 | 538 | 0.190 |
Why?
| | Biomedical Technology | 1 | 2024 | 49 | 0.190 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 79 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 375 | 0.190 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 56 | 0.190 |
Why?
| | Cell Line | 4 | 2017 | 2882 | 0.190 |
Why?
| | Respiratory System | 1 | 2024 | 149 | 0.190 |
Why?
| | Oxygen Consumption | 2 | 2022 | 724 | 0.180 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 178 | 0.180 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 107 | 0.180 |
Why?
| | Primary Cell Culture | 2 | 2013 | 174 | 0.180 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1253 | 0.180 |
Why?
| | Congresses as Topic | 1 | 2023 | 221 | 0.170 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 263 | 0.170 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 9 | 0.170 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.170 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.170 |
Why?
| | Flow Cytometry | 4 | 2015 | 1173 | 0.170 |
Why?
| | Influenza A virus | 1 | 2022 | 113 | 0.170 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.170 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.170 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 41 | 0.170 |
Why?
| | Lectins | 1 | 2021 | 45 | 0.170 |
Why?
| | Cell Size | 1 | 2021 | 92 | 0.170 |
Why?
| | Cytoskeleton | 3 | 2011 | 195 | 0.170 |
Why?
| | Kinetics | 3 | 2015 | 1629 | 0.170 |
Why?
| | Societies, Medical | 2 | 2023 | 887 | 0.170 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.160 |
Why?
| | Blotting, Western | 4 | 2011 | 1187 | 0.160 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.160 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 25 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2021 | 115 | 0.160 |
Why?
| | Microtubules | 1 | 2003 | 286 | 0.160 |
Why?
| | Integrin beta1 | 1 | 2020 | 33 | 0.160 |
Why?
| | Risk Factors | 5 | 2024 | 10792 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 298 | 0.160 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 91 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2020 | 58 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 79 | 0.160 |
Why?
| | Lactic Acid | 1 | 2022 | 302 | 0.160 |
Why?
| | Tobacco Smoking | 1 | 2020 | 26 | 0.160 |
Why?
| | Dronabinol | 1 | 2023 | 247 | 0.160 |
Why?
| | Sirolimus | 1 | 2021 | 281 | 0.160 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 78 | 0.160 |
Why?
| | Oxidants | 2 | 2011 | 103 | 0.150 |
Why?
| | Stromal Cells | 2 | 2017 | 125 | 0.150 |
Why?
| | Ischemia | 2 | 2018 | 421 | 0.150 |
Why?
| | Biological Assay | 2 | 2021 | 128 | 0.150 |
Why?
| | Cell Membrane | 3 | 2013 | 706 | 0.150 |
Why?
| | Collagen Type V | 2 | 2009 | 4 | 0.150 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 17 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2017 | 3608 | 0.140 |
Why?
| | Exercise Test | 1 | 2022 | 634 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 381 | 0.140 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 8 | 0.140 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 193 | 0.140 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 163 | 0.140 |
Why?
| | Fatty Acids | 1 | 2022 | 452 | 0.140 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 177 | 0.140 |
Why?
| | Cell Survival | 3 | 2018 | 1098 | 0.140 |
Why?
| | Eosinophils | 1 | 2021 | 316 | 0.140 |
Why?
| | Paclitaxel | 2 | 2014 | 256 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 210 | 0.140 |
Why?
| | Benzylamines | 1 | 2018 | 43 | 0.140 |
Why?
| | beta Catenin | 1 | 2020 | 253 | 0.140 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.140 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 4 | 0.140 |
Why?
| | Imipramine | 1 | 2018 | 11 | 0.140 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 43 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 43 | 0.140 |
Why?
| | Hot Temperature | 1 | 2021 | 407 | 0.140 |
Why?
| | Gene Expression | 2 | 2021 | 1490 | 0.140 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 89 | 0.130 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 140 | 0.130 |
Why?
| | Oxygen | 2 | 2014 | 995 | 0.130 |
Why?
| | Morphine | 2 | 2009 | 171 | 0.130 |
Why?
| | Aged | 6 | 2026 | 25947 | 0.130 |
Why?
| | Cell Hypoxia | 4 | 2020 | 247 | 0.130 |
Why?
| | Carbon Monoxide | 1 | 2018 | 82 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 479 | 0.130 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 75 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 548 | 0.130 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 286 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2020 | 422 | 0.130 |
Why?
| | Adult | 10 | 2022 | 40506 | 0.120 |
Why?
| | THP-1 Cells | 1 | 2016 | 20 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 292 | 0.120 |
Why?
| | Bone Marrow | 1 | 2018 | 306 | 0.120 |
Why?
| | Transcriptome | 3 | 2018 | 1046 | 0.120 |
Why?
| | Adipocytes | 1 | 2018 | 223 | 0.120 |
Why?
| | Spinal Cord | 2 | 2009 | 382 | 0.120 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 46 | 0.120 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 97 | 0.120 |
Why?
| | Time Factors | 3 | 2018 | 7183 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 315 | 0.120 |
Why?
| | Protein Binding | 3 | 2018 | 2276 | 0.120 |
Why?
| | Bronchi | 1 | 2017 | 267 | 0.120 |
Why?
| | Monocrotaline | 1 | 2015 | 32 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1695 | 0.110 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 74 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.110 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 86 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 1768 | 0.110 |
Why?
| | Lung Transplantation | 2 | 2009 | 338 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 947 | 0.110 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 388 | 0.110 |
Why?
| | Actins | 3 | 2018 | 425 | 0.110 |
Why?
| | Ventricular Pressure | 1 | 2015 | 52 | 0.110 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 59 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Binding, Competitive | 1 | 2015 | 193 | 0.110 |
Why?
| | Myelopoiesis | 1 | 2015 | 10 | 0.110 |
Why?
| | Neutrophils | 1 | 2021 | 1134 | 0.110 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.110 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 143 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 85 | 0.110 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 111 | 0.110 |
Why?
| | Aging | 2 | 2021 | 1966 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 300 | 0.110 |
Why?
| | Collagen Type VI | 1 | 2014 | 5 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 420 | 0.110 |
Why?
| | Hexuronic Acids | 1 | 2014 | 23 | 0.110 |
Why?
| | Glucuronic Acid | 1 | 2014 | 25 | 0.110 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 251 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2925 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 204 | 0.110 |
Why?
| | Arterial Pressure | 1 | 2015 | 136 | 0.100 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 40 | 0.100 |
Why?
| | Propylene Glycols | 2 | 2014 | 27 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 460 | 0.100 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 50 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 75 | 0.100 |
Why?
| | Hyperoxia | 1 | 2015 | 99 | 0.100 |
Why?
| | HMGB1 Protein | 1 | 2014 | 51 | 0.100 |
Why?
| | Ligands | 3 | 2023 | 674 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 55 | 0.100 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 248 | 0.100 |
Why?
| | Paracrine Communication | 1 | 2014 | 67 | 0.100 |
Why?
| | Metabolome | 1 | 2017 | 384 | 0.100 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 49 | 0.100 |
Why?
| | Oligopeptides | 2 | 2014 | 269 | 0.100 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 276 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 197 | 0.100 |
Why?
| | Virulence | 1 | 2014 | 280 | 0.100 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 5 | 0.100 |
Why?
| | Calpain | 1 | 2013 | 61 | 0.100 |
Why?
| | Glycolysis | 1 | 2015 | 340 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 439 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 557 | 0.100 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 35 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 16 | 0.100 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 18 | 0.100 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 49 | 0.100 |
Why?
| | Cattle | 3 | 2008 | 1000 | 0.090 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 311 | 0.090 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 44 | 0.090 |
Why?
| | HIV Infections | 3 | 2017 | 3154 | 0.090 |
Why?
| | Lung Compliance | 1 | 2012 | 42 | 0.090 |
Why?
| | United States | 4 | 2024 | 15988 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2147 | 0.090 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 297 | 0.090 |
Why?
| | Proteolysis | 1 | 2013 | 173 | 0.090 |
Why?
| | Neuralgia | 1 | 2014 | 146 | 0.090 |
Why?
| | Drug Tolerance | 2 | 2009 | 100 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 66 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 48 | 0.090 |
Why?
| | Liposomes | 1 | 2014 | 250 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5872 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 64 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 437 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 7 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 179 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1311 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 130 | 0.090 |
Why?
| | Goblet Cells | 1 | 2011 | 22 | 0.080 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 153 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1054 | 0.080 |
Why?
| | Bronchioles | 1 | 2011 | 29 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2013 | 395 | 0.080 |
Why?
| | Microcirculation | 1 | 2011 | 138 | 0.080 |
Why?
| | Immunization, Passive | 1 | 2011 | 87 | 0.080 |
Why?
| | Permeability | 1 | 2011 | 168 | 0.080 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.080 |
Why?
| | Inflammasomes | 1 | 2012 | 146 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 187 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2011 | 139 | 0.080 |
Why?
| | Phosphorylation | 1 | 2015 | 1733 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 233 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2010 | 114 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 397 | 0.080 |
Why?
| | Carcinogens | 1 | 2011 | 123 | 0.080 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 56 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 627 | 0.080 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 1143 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 419 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 194 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 939 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 49 | 0.080 |
Why?
| | Perfusion | 1 | 2011 | 250 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 570 | 0.080 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 10 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 139 | 0.080 |
Why?
| | Exercise | 1 | 2022 | 2201 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 428 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1718 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 430 | 0.070 |
Why?
| | Clathrin | 1 | 2009 | 26 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 89 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2013 | 699 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2017 | 2832 | 0.070 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 37 | 0.070 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1087 | 0.070 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 415 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2014 | 760 | 0.070 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 12 | 0.070 |
Why?
| | Mutation | 1 | 2020 | 4099 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 847 | 0.070 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 95 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 102 | 0.070 |
Why?
| | Protein Precursors | 1 | 2009 | 137 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1496 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3550 | 0.070 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 218 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 266 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 846 | 0.070 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 49 | 0.070 |
Why?
| | Cyclosporine | 1 | 2009 | 265 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 266 | 0.070 |
Why?
| | Software | 1 | 2013 | 692 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 2114 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 289 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 252 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 159 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 364 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 55 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 204 | 0.070 |
Why?
| | Obesity | 2 | 2020 | 3082 | 0.060 |
Why?
| | Antibody Formation | 1 | 2008 | 294 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 336 | 0.060 |
Why?
| | Organ Size | 1 | 2008 | 463 | 0.060 |
Why?
| | Cell-Free System | 1 | 2006 | 53 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 768 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2584 | 0.060 |
Why?
| | Cisplatin | 1 | 2008 | 334 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 540 | 0.060 |
Why?
| | Indoles | 1 | 2009 | 501 | 0.060 |
Why?
| | Capillaries | 1 | 2006 | 124 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1182 | 0.060 |
Why?
| | Antigens, CD | 2 | 2011 | 555 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 54 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1769 | 0.060 |
Why?
| | Acyltransferases | 1 | 2005 | 78 | 0.050 |
Why?
| | Deoxyguanosine | 1 | 2004 | 25 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1796 | 0.050 |
Why?
| | Regeneration | 1 | 2006 | 197 | 0.050 |
Why?
| | Weight Loss | 1 | 2010 | 837 | 0.050 |
Why?
| | Disease Progression | 1 | 2012 | 2852 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2008 | 893 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 12 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 18 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 24 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 81 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 47 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 136 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 83 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 586 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 405 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1524 | 0.040 |
Why?
| | Imidazoles | 1 | 2003 | 254 | 0.040 |
Why?
| | Cell Communication | 1 | 2023 | 324 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 359 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 377 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 314 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2642 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1504 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Fever | 1 | 2022 | 312 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2197 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 7 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 85 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1642 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 758 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 737 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 37 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 575 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 361 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 605 | 0.040 |
Why?
| | Swine | 1 | 2021 | 833 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 367 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 376 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5965 | 0.040 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.040 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 27 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2020 | 261 | 0.030 |
Why?
| | Propionates | 1 | 2018 | 39 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2022 | 528 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1077 | 0.030 |
Why?
| | Vital Capacity | 1 | 2018 | 290 | 0.030 |
Why?
| | Protein Stability | 1 | 2018 | 178 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
| | Nitriles | 1 | 2018 | 205 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 123 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 161 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1407 | 0.030 |
Why?
| | RNA | 1 | 2023 | 940 | 0.030 |
Why?
| | HIV | 1 | 2017 | 250 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 559 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 119 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 853 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 549 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1813 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 662 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2119 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 80 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 170 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 278 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 61 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 104 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 138 | 0.030 |
Why?
| | Indans | 1 | 2014 | 13 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1049 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 37 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 144 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 316 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 243 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 14126 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 547 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 84 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 577 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 60 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 136 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 97 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 118 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 128 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 171 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 833 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17101 | 0.020 |
Why?
| | Cricetinae | 1 | 2013 | 304 | 0.020 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 4 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 131 | 0.020 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 23 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 610 | 0.020 |
Why?
| | Lipid Bilayers | 1 | 2014 | 103 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 42 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1890 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 132 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 55 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 160 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 39 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 165 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 902 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 573 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 509 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 202 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 336 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 222 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1241 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1026 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 57 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 73 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 171 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 553 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 389 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1990 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 103 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2330 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 55 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 76 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 121 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2507 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 508 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 9 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 246 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 54 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 125 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 153 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1486 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 848 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1048 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 930 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8279 | 0.010 |
Why?
| | Pleura | 1 | 2005 | 28 | 0.010 |
Why?
| | Ligation | 1 | 2005 | 92 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1839 | 0.010 |
Why?
| | Postural Balance | 1 | 2008 | 240 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 121 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 113 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 82 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 418 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 244 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 877 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1982 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 998 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11695 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1822 | 0.010 |
Why?
| | Child | 1 | 2017 | 22657 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|